Federal Register / Vol. 62, No. 180 / Wednesday, September 17, 1997 / Notices 48871

Resources Management (HFA–250),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–827–1479.

SUPPLEMENTARY INFORMATION: In

compliance with section 3507 of the

PRA (44 U.S.C. 3507), FDA has

submitted the following proposed

collection of information to OMB for

review and clearance:

Notice of Availability of Sample

Electronic Product—21 CFR Parts 1020,

1030, 1040, and 1050 and FDA Form

2767 (OMB Control No. 0910–0048—

Reinstatement)

Under sections 532 through 542 of the

Federal Food, Drug, and Cosmetic Act

(the act) (21 U.S.C. 360ii through 360ss),

FDA regulates electronic products that

emit radiation. Section 532 of the act

directs the Secretary of the Department

of Health and Human Services (the

Secretary) to establish and carry out an

electronic product radiation control

program designed to protect the public

health and safety from electronic

radiation, and authorizes the Secretary

to procure (by negotiation or otherwise)

electronic products for research and

testing purposes and to sell or otherwise

dispose of such products.

FDA’s Center for Devices and

Radiological Health (CDRH) conducts

laboratory compliance testing of

products covered by regulations for

product standards in parts 1020, 1030,

1040, and 1050 (21 CFR parts 1020,

1030, 1040, and 1050). The ‘‘Notice of

Availability of Sample Electronic

Product’’ (Form FDA 2767) is used to

inform CDRH of the location of sample

products that are being requested for

testing to confirm that the products

comply with performance standards.

Form FDA 2767 is a summary form

which reports information as required

by parts 1020, 1030, 1040, and 1050.

FDA also uses this information to

locate and select sample products to

ensure conformance with regulations. In

the event this information were not

collected by CDRH, each manufacturer

would have to respond in letter format

with all the data now being recorded on

Form FDA 2767, which would require

more time and expense. Testing an

appropriate percentage of these

products to protect the public would

also be hindered by the slower process.

The respondents to this collection of

information are manufacturers of

electronic products.

FDA estimates the burden of this

collection of information as follows:

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN

21 CFR Part and Form Number No. of

Respondents

Annual

Frequency per

Response

Total Annual

Responses

Hours per

Response Total Hours

1020, 1030, 1040, 1050, and Form FDA 2767 145 11.03 1,600 0.09 144

Totals 144

There are no capital costs or operating and maintenance costs associated with this collection of information.

FDA’s estimates are based on actual

data collected from industry over the

past 3 years, where there has been an

average of 1,600 annual responses to

FDA from 145 respondents each year.

Dated: September 9, 1997.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 97–24581 Filed 9–16–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA–R–52]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimate burden;

(3) ways to enhance the quality, utility,

and clarity of the information to be

collected; and (4) the use of automated

collection techniques or other forms of

information technology to minimize the

information collection burden.

Type of Information Collection

Request: Revision of a currently

approved collection; Title of

Information Collection: Conditions for

Coverage of Supplier of End Stage Renal

Disease (ESRD) Services and Supporting

Regulations Contained in 42 CFR

405.2100–2171; Document No.: HCFA–

R–52 (OMB#0938–0386); Use: These

conditions of coverage are needed to

ensure proper distribution and effective

utilization of ESRD treatment sources.

In addition, the conditions maintain and

improve the efficient delivery of care by

physicians and dialysis facilities;

Frequency: Annually; Affected Public:

Business or other for-profit, and Federal

Government; Number of Respondents:

2,976; Total Annual Responses: 2,976,

Total Annual Hours: 100,937.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, E-mail your request,

including your address, phone number,

OMB number, and HCFA document

identifier to Paperwork@hcfa.gov, or

call the Reports Clearance Office on

(410) 786–1326. Written comment and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Information Technology Investment

Management Group, Division of HCFA

Enterprise Standards, Attention: Louis

Blank, Room C2–26–17, 7500 Security

Boulevard, Baltimore, Maryland, 21244–

1850.

Dated: September 10, 1997.

John P. Burke III,

HCFA Reports Clearance Officer, HCFA Office

of Information Services, Information

Technology Investment Management Group,

Division of HCFA Enterprise Standards.

[FR Doc. 97–24652 Filed 9–16–97; 8:45 am]

BILLING CODE 4120–03–M